Pharmacologic and Nonpharmacologic Management of Atrial Fibrillation
Title
Pharmacologic and Nonpharmacologic Management of Atrial Fibrillation
Creator
Dahya Vishal; Taigen Tyler L
Publisher
Medical Clinics of North America
Date
2019
2019-09
Description
Atrial fibrillation (AF) is the most common arrhythmia and its management may be organized into risk stratification and/or treatment of heart failure, stroke prevention, and symptom control. At the core of symptom control, treatment is tailored to either allow AF continue with controlled heart rates, so-called rate control, versus restoring and maintaining sinus rhythm or rhythm control. Rate control strategies mainly use rate-modulating medications, whereas rhythm control treatment includes therapy aimed at restoring sinus rhythm, including pharmacologic and direct current cardioversion, as well as maintenance of sinus rhythm, including anti-arrhythmic medications and ablation therapy.
Subject
amiodarone; Antiarrhythmic drugs; antiarrhythmic-drugs; Atrial fibrillation; cardioversion; catheter ablation; Catheter ablation; dronedarone; efficacy; heart-failure; maintaining sinus rhythm; mortality; Pharmacologic management; therapy
October 2019 Update
Identifier
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
URL Address
Search for Full-text
Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home
Pages
835-+
Issue
5
Volume
103
NEOMED College
NEOMED College of Medicine
Citation
Dahya Vishal; Taigen Tyler L, “Pharmacologic and Nonpharmacologic Management of Atrial Fibrillation,” NEOMED Bibliography Database, accessed May 7, 2024, https://neomed.omeka.net/items/show/6560.